Connor, Clark & Lunn Investment Management (CC&L)
DMTK

Connor, Clark & Lunn Investment Management (CC&L)’s DermTech, Inc. Common Stock DMTK Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,126
Closed -$795K – 1253
2021
Q2 		$795K Buy
+19,126
New +$786K ﹤0.01% 705

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s DMTK Position: Q3 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 19,126 shares — an estimated $795K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DMTK in Q2 2021 and held it in 1 quarter. The position peaked at $795K in Q2 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 19,126 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $795K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s DermTech, Inc. Common Stock position peaked at $795K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2021, filed 12 Nov 2021.